For this action, the firm cited the potential of Nuvation Bio’s glioma drug candidate, safusidenib. First, RBC Capital ...
Nuvation Bio, Inc. (NYSE: NUVB) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock’s price ...
Shares of Nuvation Bio (NYSE: NUVB) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday. The big jump came after two positive developments for the cancer-focused drugmaker. Which news ...
7 analysts have shared their evaluations of Nuvation Bio (NYSE:NUVB) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results